Sugammadex: the first selective binding reversal agent for neuromuscular block

Journal of clinical anesthesia

Volumn 21, Issue 6, 2009, Pages 444-453

  Kovac, Anthony L ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANE DERIVATIVE; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT; ROCURONIUM; SUGAMMADEX; VECURONIUM;

ANIMAL; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL (TOPIC); DOSE RESPONSE; HUMAN; NEUROMUSCULAR BLOCKING; PROCEDURES;

ANDROSTANOLS; ANIMALS; CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-CYCLODEXTRINS; HUMANS; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; VECURONIUM BROMIDE;

EID: 77952719827     PISSN: None     EISSN: 18734529     Source Type: Journal    
DOI: 10.1016/j.jclinane.2009.05.002     Document Type: Review

References (0)